SCHEMBL6637397

SCHEMBL6637397

CC(C)c1cccc(C(C)C)c1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.59
FABP4 P15090 1/20 0.59
GABRA1 P14867 4/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
LMNA P02545 2/20 0.52
GABRG2 P18507 2/20 0.52
GABRB3 P28472 2/20 0.52
GABRB2 P47870 2/20 0.52
GABRB1 P18505 2/20 0.52
FAAH O00519 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
PTGS1 P23219 1/20 0.52
SLC6A2 P23975 1/20 0.52
HTR2C P28335 1/20 0.52
GABRA5 P31644 1/20 0.52
GABRA3 P34903 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961934 0.87 CA1 (0.61) FABP3FABP4GABRA1CA1CA2
SCHEMBL1356418 0.87 FABP3 (0.47) FABP3FABP4GABRA1CA1CA2
SCHEMBL6235887 0.87 TDP1 (0.49) FABP3FABP4GABRA1CA1CA2
SCHEMBL17755148 0.86 CES2 (0.48) FABP3FABP4GABRA1CA1CA2
SCHEMBL10489985 0.86 FABP3 (0.46) FABP3FABP4GABRA1CA1CA2
SCHEMBL343203 0.86 FABP3 (0.46) FABP3FABP4GABRA1CA1CA2
SCHEMBL14564313 0.86 ITGB1 (0.50) FABP3FABP4GABRA1CA1CA2
Isopropyl Alcohol SCHEMBL8992570 0.84 FABP3 (0.44) FABP3FABP4GABRA1CA1CA2
SCHEMBL28217218 0.84 FABP3 (0.44) FABP3FABP4GABRA1CA1CA2
SCHEMBL28217225 0.84 FABP3 (0.44) FABP3FABP4GABRA1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107056587-B Method for synthesizing L-menthol 福建青松股份有限公司 2020-06-05 CN claimed
CN-107056587-A A kind of method of synthesis L menthols 福建青松股份有限公司 2017-08-18 CN claimed
CN-101003456-B Method for preparing Beta, Gamma unsaturated ester CHINA PETROCHEMICAL CORP 2010-10-06 CN claimed
CN-101003456-A Method for preparing Beta, Gamma unsaturated ester CHINA PETROCHEMICAL CORP (CN) 2007-07-25 CN claimed
US-6010975-A Catalyst composition for preparing 3-pentenoic ester from butadiene INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2000-01-04 US claimed
US-20250162992-A1 METHOD FOR PRODUCING AMIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-05-22 US disclosed
EP-4461724-A1 METHOD FOR PRODUCING AMIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-11-13 EP disclosed
US-20230367214-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-16 US disclosed
US-20230367214-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-16 US disclosed
US-20230367213-A1 MASK BLANK, RESIST PATTERN FORMING PROCESS AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-16 US disclosed
US-20230367213-A1 MASK BLANK, RESIST PATTERN FORMING PROCESS AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-16 US disclosed
EP-4276533-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2023-11-15 EP disclosed
EP-0742208-A1 2-Ureido-benzamide derivatives GRELAN PHARMACEUTICAL CO., LTD. (JP) 1996-11-13 EP disclosed
US-5442060-A Treating hyperlipemia, atherosclerosis MITSUBISHI KASEI CORPORATION (JP) 1995-08-15 US disclosed
EP-0625507-A2 Urea derivatives and their use as acat inhibitors NISSHIN FLOUR MILLING CO., LTD. (JP) 1994-11-23 EP disclosed
EP-0591830-A1 Carboxamide and urea derivatives having ACAT-inhibiting activityM Mitsubishi Chemical Corporation (JP) 1994-04-13 EP disclosed
EP-0507576-A1 Polypropylene-based resin compositions TOSOH CORPORATION (JP) 1992-10-07 EP disclosed
US-3985797-A Hydroxylation of aromatic compounds UOP INC. (US) 1976-10-12 US disclosed
US-3985796-A Hydroxylation of aromatic compounds UOP INC. (US) 1976-10-12 US disclosed
US-3931295-A Hydroxylation of aromatic compounds UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250162992-A1 METHOD FOR PRODUCING AMIDE COMPOUND NAAA, NCAPH, NCAPD2 FABP3 3421/4885FABP4 1877/4885GABRA1 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.